about
Bone marrow cell graft engineering: from bench to bedside.Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome.Bone marrow T cells are superior to splenic T cells to induce chimeric conversion after non-myeloablative bone marrow transplantationMyeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene.
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clinical applications of mixed chimerism.
@ast
Clinical applications of mixed chimerism.
@en
type
label
Clinical applications of mixed chimerism.
@ast
Clinical applications of mixed chimerism.
@en
prefLabel
Clinical applications of mixed chimerism.
@ast
Clinical applications of mixed chimerism.
@en
P2093
P2860
P1476
Clinical applications of mixed chimerism.
@en
P2093
Bergheim M
Domenick MA
Ildstad ST
Mueller YM
P2860
P304
377-85; discussion 385-6
P356
10.1111/J.1749-6632.1999.TB08482.X
P407
P577
1999-04-01T00:00:00Z